A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer
PHASE2
This is a phase II study evaluating a new combination therapy for untreated...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial
PHASE2
This study aims to conduct a prospective, multicenter, randomized controlle...
Status
Withdrawn
Location
Womens' Hosptial, School of Medicine, Zhejiang University